SMG
IBB icon

Spectrum Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Spectrum Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$20K Hold
173
– – ﹤0.01% 166
2022
Q2 		$20K Hold
173
– – ﹤0.01% 166
2022
Q1 		$23K Buy
+173
New +$22.5K ﹤0.01% 186

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Spectrum Management Group's IBB Position: Q3 2022 in Review

Spectrum Management Group held its iShares Biotechnology ETF (IBB) position steady in Q3 2022 at 173 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Spectrum Management Group first reported a position in IBB in Q1 2022 and has held it in 3 quarters since. The position peaked at $23K in Q1 2022. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • Spectrum Management Group held 173 shares of iShares Biotechnology ETF worth $20K as of Q3 2022.
  • Spectrum Management Group left its iShares Biotechnology ETF share count unchanged in Q3 2022.
  • iShares Biotechnology ETF made up ﹤0.01% of Spectrum Management Group's portfolio in Q3 2022, its #166 holding.
  • Spectrum Management Group first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 3 quarters since.
  • Spectrum Management Group's iShares Biotechnology ETF position peaked at $23K in Q1 2022.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Spectrum Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.